Session Details

[27-55-pm1]Clinical Pharmacy 5, Appropriate use of medicines/Pharmacotherapies (Basics)

Fri. Mar 27, 2026 1:10 PM - 3:10 PM JST
Fri. Mar 27, 2026 4:10 AM - 6:10 AM UTC
Room 55 (C202, Bldg. 2, Area 2 [2F]) (1)
Discusser: Junji Saruwatari, Masayuki Tsujimoto

[27-55-pm1-01S]The effects of beta-blocker in patients with pacemaker
implantation

○Misaki Yamaguchi1, Hiroyuki Motoishi1,2, Naoya Kimura2, Hiroshi Inagaki3, Kazuki Aida1, Reiko Ishii-Nozawa1 (1. Meiji Pharmaceut. Univ., 2. Dept. of Pharmacy, Soka Municipal Hospital, 3. Dept. of Cardiology, Soka Municipal Hospital)

[27-55-pm1-02S]Survey of heart failure treatment at Soka City Hospital using a heart failure assessment sheet

○Hina Watanabe1, Hiroyuki Motoishi2,1, Naoya Kimura2, Hiroshi Inagaki3, Kazuki Aida1, Reiko Ishii-Nozawa1 (1. Meiji Pharmaceut. Univ., 2. Dept. of Pharmacy, Soka Municipal Hospital, 3. Dept. of Cardiology, Soka Municipal Hospital)

[27-55-pm1-03S]Effects of thickeners and fibers in enteral nutrient formulations on levetiracetam permeability via Caco-2 monolayer cell membranes

○Mirika Yano1, Yoko Urashima1, Kazuya Urashima2, Tomoyuki Yamada3, Kazumi Kurachi3, Masami Nishihara3, Akira Ashida3, Kazumi Umemoto 1, Tokio Obata1 (1. Pharm., Osaka Ohtani Univ., 2. Pharm., JCHO Osaka Minato Center Hosp. , 3. Pharm., Osaka Med. and Pharm. Univ. Hosp.)

[27-55-pm1-04S]Investigation of the concomitant use of DOAC and enzyme-inducing antiseizures in patients with NVAF: a retrospective cohort study using the JMDC Health Insurance Database

○Koki Fukuta1, Ryo Iketani1, Tomiko Sunaga1,2, Takuaki Tani1, Shinobu Imai1 (1. Grad. Sch. Pharm., Showa Med. Univ., 2. Hoshi Univ.)

[27-55-pm1-05]Development of an AI-generated prompt for automatic detection of polypharmacy and its application to clinical practice and pharmacy education

○Nobuhito Shibata1, Miho Manabe2, Masami Terai2, Koki Takeda1, Asako Nishimura1 (1. Sch. Pharm. Sci.,Doshisha Women's Univ. , 2. Kyoto Kizugawa Hospital Pharmacy Dept.)

[27-55-pm1-06S]Stepwise Proteolytic Processing of Neuroligin-3 and the Impact of ASD-Associated Mutations

○Daiki Takabe1, Momoka Uratani1, Shota Ochi1, Shun Inoue1, Kosuke Fukunaga1, Seisuke Tokuyama1, Nao Yamaguchi1, Takako Yamaguchi1, Jun Kanamune1, Kanta Yanagida1,2, Akio Fukumori1,2,3 (1. Osaka Med. & Pharm. Univ., 2. Grad. Sch. Med, Osaka Univ., 3. Aging Neuro. Bio., Natl. Ctr. for Geriatr. & Gerontol.)

[27-55-pm1-07S]Dietary-Derived Modulators of Amyloid-β Production: Potential Applications for Alzheimer’s Disease Prevention

○Moe Takai1, Seisuke Tokuyama1, Kosuke Fukunaga1, Nao Yamaguchi1, Takako Yamaguchi1, Kanta Yanagida1,2, Yoshiyuki Hirata1, Shinichi Uesato1, Akio Fukumori1,2,3 (1. Osaka Med. & Pharm. Univ., 2. Grad. Sch. Med, Osaka Univ., 3. Aging Neuro. Bio., Natl. Ctr. for Geriatr. & Gerontol.)